Antiviral activity of lambda interferon in chickens

Journal of Virology

Volumn 88, Issue 5, 2014, Pages 2835-2843

  Reuter, Antje ^a,c   Soubies, Sebastien ^a   Härtle, Sonja ^b   Schusser, Benjamin ^b   Kaspers, Bernd ^b   Staeheli, Peter ^a   Rubbenstroth, Dennis ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; INTERFERON; LAMBDA INTERFERON; MYXOVIRUS RESISTANCE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CHICKEN; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; IL28RA GENE; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA VIRUS A; MOLECULAR MECHANICS; MX GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RETROVIRAL GENE TRANSFER VECTOR SYSTEM; TRANSCRIPTION REGULATION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIVIRAL AGENTS; CELL LINE; CHICK EMBRYO; CHICKENS; DISEASE RESISTANCE; FIBROBLASTS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENES, LETHAL; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INTERFERONS; MOLECULAR SEQUENCE DATA; MYXOVIRUS RESISTANCE PROTEINS; RECEPTORS, CYTOKINE; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; TISSUE CULTURE TECHNIQUES; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 84896723818     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02764-13     Document Type: Article

References (31)

1. Randall RE, Goodbourn S. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89:1-47. http://dx.doi.org/10.1099/vir.0.83391-0.
2. Hardy MP, Sanij EP, Hertzog PJ, Owczarek CM. 2003. Characterization and transcriptional analysis of the mouse chromosome 16 cytokine receptor gene cluster. Mamm. Genome. 14:105-118. http://dx.doi.org/10.1007 /s00335-002-2225-0.
3. Hardy MP, Owczarek CM, Trajanovska S, Liu X, Kola I, Hertzog PJ. 2001. The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties. Blood 97:473-482. http://dx.doi.org/10.1182/blood.V97.2 .473.
4. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP. 2003. IFNlambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4:69-77. http://dx.doi.org/10.1038/ni875.
5. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4:63-68. http://dx.doi.org/10.1038/ni873.
6. Sommereyns C, Paul S, Staeheli P, Michiels T. 2008. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog. 4:e1000017. http://dx.doi.org/10.1371/journal.ppat.1000017.
7. Nagalakshmi ML, Murphy E, McClanahan T, de Waal Malefyt R. 2004. Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. Int. Immunopharmacol. 4:577-592. http://dx.doi.org/10.1016/j.intimp.2004.01.007.
8. Mordstein M, Kochs G, Dumoutier L, Renauld JC, Paludan SR, Klucher K, Staeheli P. 2008. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog. 4:e1000151. http://dx.doi.org/10.1371/journal.ppat.1000151.
9. Pott J, Mahlakoiv T, Mordstein M, Duerr CU, Michiels T, Stockinger S, Staeheli P, Hornef MW. 2011. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc. Natl. Acad. Sci. U. S. A. 108:7944-7949. http://dx.doi.org/10.1073/pnas.1100552108.
10. Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR. 2006. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 80:4501-4509. http://dx.doi.org/10.1128/JVI.80.9.4501-4509.2006.
11. Dumoutier L, Tounsi A, Michiels T, Sommereyns C, Kotenko SV, Renauld JC. 2004. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J. Biol. Chem. 279:32269-32274. http://dx.doi.org/10.1074/jbc.M404789200.
12. Lasfar A, Lewis-Antes A, Smirnov SV, Anantha S, Abushahba W, Tian B, Reuhl K, Dickensheets H, Sheikh F, Donnelly RP, Raveche E, Kotenko SV. 2006. Characterization of the mouse IFN-lambda ligandreceptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma. Cancer Res. 66:4468-4477. http://dx.doi.org/10.1158/0008-5472.CAN-05-3653.
13. Kaiser P. 2010. Advances in avian immunology-prospects for disease control: a review. Avian Pathol. 39:309-324. http://dx.doi.org/10.1080/03079457.2010.508777.
14. Sick C, Schultz U, Staeheli P. 1996. A family of genes coding for two serologically distinct chicken interferons. J. Biol. Chem. 271:7635-7639. http://dx.doi.org/10.1074/jbc.271.13.7635.
15. Plachy J, Weining KC, Kremmer E, Puehler F, Hala K, Kaspers B, Staeheli P. 1999. Protective effects of type I and type II interferons toward Rous sarcoma virus-induced tumors in chickens. Virology 256:85-91. http://dx.doi.org/10.1006/viro.1999.9602.
16. Penski N, Hartle S, Rubbenstroth D, Krohmann C, Ruggli N,Schusser B, Pfann M, Reuter A, Gohrbandt S, Hundt J, Veits J, Breithaupt A, Kochs G, Stech J, Summerfield A, Vahlenkamp T, Kaspers B, Staeheli P. 2011. Highly pathogenic avian influenza viruses do not inhibit interferon synthesis in infected chickens but can override the interferon-induced antiviral state. J. Virol. 85:7730-7741. http://dx.doi.org/10.1128/JVI.00063-11.
17. Karpala AJ, Morris KR, Broadway MM, McWaters PG, O'Neil TE, Goossens KE, Lowenthal JW, Bean AG. 2008. Molecular cloning, expression, and characterization of chicken IFN-lambda. J. Interferon Cytokine Res. 28:341-350. http://dx.doi.org/10.1089/jir.2007.0117.
18. Masuda Y, Matsuda A, Usui T, Sugai T, Asano A, Yamano Y. 2012. Biological effects of chicken type III interferon on expression of interferonstimulated genes in chickens: comparison with type I and type II interferons. J. Vet. Med. Sci. 74:1381-1386. http://dx.doi.org/10.1292/jvms.11-0517.
19. Hughes SH. 2004. The RCAS vector system. Folia Biol. (Praha) 50:107-119.
20. Kothlow S, Schenk-Weibhauser K, Ratcliffe MJ, Kaspers B. 2010. Prolonged effect of BAFF on chicken B cell development revealed by RCAS retroviral gene transfer in vivo. Mol. Immunol. 47:1619-1628. http://dx.doi.org/10.1016/j.molimm.2010.01.011.
21. Boritz E, Gerlach J, Johnson JE, Rose JK. 1999. Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. J. Virol. 73:6937-6945.
22. Esnault E, Bonsergent C, Larcher T, Bed'hom B, Vautherot JF, Delaleu B, Guigand L, Soubieux D, Marc D, Quere P. 2011. A novel chicken lung epithelial cell line: characterization and response to low pathogenicity avian influenza virus. Virus Res. 159:32-42. http://dx.doi.org/10.1016/j.virusres.2011.04.022.
23. Schultz U, Rinderle C, Sekellick MJ, Marcus PI, Staeheli P. 1995. Recombinant chicken interferon from Escherichia coli and transfected COS cells is biologically active. Eur. J. Biochem. 229:73-76. http://dx.doi.org/10.1111/j.1432-1033.1995.0073l.x.
24. Fouchier RA, Bestebroer TM, Herfst S, Van Der Kemp L, Rimmelzwaan GF, Osterhaus AD. 2000. Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene. J. Clin. Microbiol. 38:4096-4101.
25. Schusser B, Reuter A, von der Malsburg A, Penski N, Weigend S, Kaspers B, Staeheli P, Hartle S. 2011. Mx is dispensable for interferonmediated resistance of chicken cells against influenza A virus. J. Virol. 85:8307-8315. http://dx.doi.org/10.1128/JVI.00535-11.
26. Yang L, Luo Y, Wei J, He S. 2010. Integrative genomic analyses on IL28RA, the common receptor of interferon-lambda1,-lambda2 and-lambda3. Int. J. Mol. Med. 25:807-812. http://dx.doi.org/10.3892/ijmm_00000408.
27. Esteban S, Rayo JM, Moreno M, Sastre M, Rial RV, Tur JA. 1991. A role played by the vitelline diverticulum in the yolk sac resorption in young post hatch chickens. J. Comp. Physiol. B 160:645-648. http://dx.doi.org/10.1007/BF00571262.
28. Noy Y, Uni Z, Sklan D. 1996. Routes of yolk utilisation in the newlyhatched chick. Br. Poult. Sci. 37:987-995. http://dx.doi.org/10.1080/00071669608417929.
29. Gresser I, Tovey MG, Maury C, Chouroulinkov I. 1975. Lethality of interferon preparations for newborn mice. Nature 258:76-78. http://dx.doi.org/10.1038/258076a0.
30. Mordstein M, Neugebauer E, Ditt V, Jessen B, Rieger T, Falcone V, Sorgeloos F, Ehl S, Mayer D, Kochs G, Schwemmle M, Gunther S, Drosten C, Michiels T, Staeheli P. 2010. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J. Virol. 84:5670-5677. http://dx.doi.org/10.1128/JVI.00272-10.
31. Perez-Martin E, Weiss M, Diaz-San Segundo F, Pacheco JM, Arzt J, Grubman MJ, de los Santos T. 2012. Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle. J. Virol. 86:4477-4487. http://dx.doi.org/10.1128/JVI.06683-11